Skip to main content
Full access
Clinical & Research
Published Online: 10 January 2020

Most Youth With OUD Who Need Medication Treatment Do Not Receive It

Although prescription opioid pain reliever misuse has dropped among youth, death rates from overdose are climbing, leading an expert in adolescent substance use treatment to question why.
Health professionals are missing opportunities to treat youth who have opioid use disorder (OUD), said Sarah M. Bagley, M.D., M.Sc., an assistant professor of medicine and pediatrics at Boston University School of Medicine, at the American Academy of Addiction Psychiatry’s 30th Annual Meeting and Scientific Sessions in San Diego last month.
“Youth with OUD experience stigma from health professionals as well as family and friends,” says Sarah M. Bagley, M.D., Sc.D.
“We did a study in Massachusetts of young adults who were in the emergency department after a nonfatal overdose. At 12 months we found that only 1 in 3 received medication treatment in that time,” Bagley told a packed house. “After a nonfatal overdose, they are at risk of a fatal overdose, and we are not treating them.”
Although the most recent National Survey on Drug Use and Health reported a decline in prescription opioid pain reliever misuse among youth and the general population, a deeper dive into the literature reveals news that is not quite so good, said Bagley, who is also medical director of the CATALYST Program. The program provides integrated medical and behavioral health care for adolescents and young adults who use substances.
“Among 15- to 19-year-olds, opioid poisonings have increased nearly threefold. Pediatric ICU admissions [for opioids] doubled between 2004 and 2015,” Bagley said, adding that fentanyl and other synthetic opioids are driving overdose death rates.
Bagley said that even though data suggest that medication treatment improves outcomes in young people overall, only 1 in 4 youth diagnosed with OUD received it between 2000 and 2014. She said that although this is largely because most health professionals who have the authority to prescribe buprenorphine for OUD treat adults, stigma may also keep youth from treatment. Bagley noted that stigma “plays out differently” in youth because they are influenced by their peers and family in ways that adults are not.
But in a troubling irony, youth also experience stigma from health professionals who question the legitimacy of medication treatment, Bagley said. She questioned whether addiction professionals who provide medication treatment should prepare young adults for resistance from other professionals.
“For other conditions, we don’t warn them of pushback. Is that something we should do?” she asked. “Should we warn them, like ‘Your pharmacist might push back or your other treatment providers may say ‘You are on what?’ What’s the framing when we start a young person on medication treatment?”
Bagley recommended three strategies to connect more youth with medication treatment: increase buprenorphine training and credentialing among health providers who treat adolescents, educate health professionals and the public about the stigma around medication treatment, and create innovative models of care. ■
The National Survey on Drug Use and Health is posted here.

Information & Authors

Information

Published In

History

Published online: 10 January 2020
Published in print: January 4, 2019 – January 17, 2020

Keywords

  1. opioids
  2. overdose
  3. opioid use disorder
  4. OUD
  5. substance use
  6. adolescent health
  7. pediatrics
  8. medication treatment
  9. buprenorphine
  10. naltrexone
  11. Sarah Bagley
  12. American Academy of Addiction Psychiatry
  13. AAAP

Authors

Details

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share